120 related articles for article (PubMed ID: 10937066)
21. Expression pattern of alpha-protein kinase C in human astrocytomas indicates a role in malignant progression.
Benzil DL; Finkelstein SD; Epstein MH; Finch PW
Cancer Res; 1992 May; 52(10):2951-6. PubMed ID: 1316231
[TBL] [Abstract][Full Text] [Related]
22. Impaired gap junction formation and intercellular calcium signaling in urinary bladder cancer cells can be improved by Gö6976.
Leinonen P; Aaltonen V; Koskela S; Lehenkari P; Korkiamäki T; Peltonen J
Cell Commun Adhes; 2007 Oct; 14(4):125-36. PubMed ID: 17957529
[TBL] [Abstract][Full Text] [Related]
23. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival.
Del Pizzo JJ; Borkowski A; Jacobs SC; Kyprianou N
Am J Pathol; 1999 Oct; 155(4):1129-36. PubMed ID: 10514396
[TBL] [Abstract][Full Text] [Related]
24. Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1.
Rausch S; Hennenlotter J; Teepe K; Kuehs U; Aufderklamm S; Bier S; Mischinger J; Gakis G; Stenzl A; Schwentner C; Todenhöfer T
Urol Oncol; 2015 Oct; 33(10):426.e21-9. PubMed ID: 26231311
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of HER2 status in bladder transitional cell carcinoma revealed by both IHC and BDISH techniques.
Nedjadi T; Al-Maghrabi J; Assidi M; Dallol A; Al-Kattabi H; Chaudhary A; Al-Sayyad A; Al-Ammari A; Abuzenadah A; Buhmeida A; Al-Qahtani M
BMC Cancer; 2016 Aug; 16():653. PubMed ID: 27539085
[TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase-2: a possible target in schistosoma-associated bladder cancer.
El-Sheikh SS; Madaan S; Alhasso A; Abel P; Stamp G; Lalani EN
BJU Int; 2001 Dec; 88(9):921-7. PubMed ID: 11851614
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase C tissue localization in human colonic tumors suggests a role for adenoma growth control.
Kahl-Rainer P; Sedivy R; Marian B
Gastroenterology; 1996 Jun; 110(6):1753-9. PubMed ID: 8964400
[TBL] [Abstract][Full Text] [Related]
28. Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas.
Kömhoff M; Guan Y; Shappell HW; Davis L; Jack G; Shyr Y; Koch MO; Shappell SB; Breyer MD
Am J Pathol; 2000 Jul; 157(1):29-35. PubMed ID: 10880372
[TBL] [Abstract][Full Text] [Related]
29. Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder.
Lazzeri M; Vannucchi MG; Spinelli M; Bizzoco E; Beneforti P; Turini D; Faussone-Pellegrini MS
Eur Urol; 2005 Oct; 48(4):691-8. PubMed ID: 15992990
[TBL] [Abstract][Full Text] [Related]
30. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
[TBL] [Abstract][Full Text] [Related]
31. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder.
Elsamman E; Fukumori T; Kasai T; Nakatsuji H; Nishitani MA; Toida K; Ali N; Kanayama HO
BJU Int; 2006 Jun; 97(6):1202-7. PubMed ID: 16686711
[TBL] [Abstract][Full Text] [Related]
32. Mucin expression by transitional cell carcinomas of the bladder.
Walsh MD; Hohn BG; Thong W; Devine PL; Gardiner RA; Samaratunga ML; McGuckin MA
Br J Urol; 1994 Mar; 73(3):256-62. PubMed ID: 8162502
[TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase-2 expression in urinary bladder transitional cell carcinoma and its association with clinicopathological characteristics.
Tabriz HM; Olfati G; Ahmadi SA; Yusefnia S
Asian Pac J Cancer Prev; 2013; 14(8):4539-43. PubMed ID: 24083698
[TBL] [Abstract][Full Text] [Related]
34. Cytochrome P450 isoenzyme mRNA expression pattern in human urinary bladder malignancies and normal urothelium.
Brauers A; Manegold E; Buettner R; Baron JM; Merk HF; Jakse G
Cancer Detect Prev; 2000; 24(4):356-63. PubMed ID: 11059566
[TBL] [Abstract][Full Text] [Related]
35. Epithelial differentiation antigens and epidermal growth factor receptors in transitional cell bladder carcinoma: correlation with prognosis.
Nakopoulou L; Zervas A; Constantinides C; Deliveliotis C; Stefanaki K; Dimopoulos C
Urol Int; 1995; 54(4):191-7. PubMed ID: 7541921
[TBL] [Abstract][Full Text] [Related]
36. Levels of acyl-coenzyme A synthetase 5 in urothelial cells and corresponding neoplasias reflect cellular differentiation.
Gaisa NT; Reinartz A; Schneider U; Klaus C; Heidenreich A; Jakse G; Kaemmerer E; Klinkhammer BM; Knuechel R; Gassler N
Histol Histopathol; 2013 Mar; 28(3):353-64. PubMed ID: 23348389
[TBL] [Abstract][Full Text] [Related]
37. Association of cyclooxygenase-2 expression with prognosis of stage T1 grade 3 bladder cancer.
Kim SI; Kwon SM; Kim YS; Hong SJ
Urology; 2002 Nov; 60(5):816-21. PubMed ID: 12429306
[TBL] [Abstract][Full Text] [Related]
38. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
King ED; Matteson J; Jacobs SC; Kyprianou N
J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878
[TBL] [Abstract][Full Text] [Related]
39. E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.
Byrne RR; Shariat SF; Brown R; Kattan MW; Morton RA JR; Wheeler TM; Lerner SP
J Urol; 2001 May; 165(5):1473-9. PubMed ID: 11342899
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of BDNF and TrkB in human bladder cancer specimens.
Lai PC; Chiu TH; Huang YT
Oncol Rep; 2010 Nov; 24(5):1265-70. PubMed ID: 20878119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]